Super Tadapox is a combination medication used to treat two common male sexual disorders: erectile dysfunction (ED) and premature ejaculation (PE). It contains two active ingredients: tadalafil and dapoxetine.

Tadalafil, one of the active ingredients in Super Tadapox, is a phosphodiesterase type 5 (PDE5) inhibitor used to treat ED. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat PE.

The reason why Super Tadapox may not be recommended for individuals with a history of certain eye conditions, such as retinitis pigmentosa, is related to the potential side effects of tadalafil, specifically its association with visual disturbances.

Retinitis pigmentosa is a rare inherited eye disorder that affects the retina and can lead to progressive vision loss over time. Individuals with retinitis pigmentosa may already have compromised retinal function, making them more susceptible to visual side effects associated with medications like tadalafil.

While rare, tadalafil has been associated with certain visual disturbances, including changes in color vision, blurred vision, and increased sensitivity to light. In some cases, these side effects can be severe and may persist even after discontinuation of the medication.

For individuals with a history of retinitis pigmentosa or other retinal disorders, the potential risk of visual side effects associated with tadalafil may outweigh the potential benefits of using Super Tadapox. Therefore, healthcare providers may exercise caution or recommend alternative treatment options for individuals with these conditions.

It's essential for individuals with a history of retinitis pigmentosa or other eye conditions to discuss their medical history with their healthcare provider before starting Super Tadapox or any other medication. A healthcare provider can assess the individual's risk factors and provide personalized recommendations based on their health needs and circumstances.